International Journal of Prosthodontics and Restorative Dentistry

Register      Login

VOLUME 11 , ISSUE 2 ( April-June, 2021 ) > List of Articles

CASE REPORT

Lead Protection and Positioning Splints before Brachytherapy in Maxillofacial Prosthodontics: A Case Report

Wijdane EL Hawari, Eddarif Oumaima, Nadia Merzouk, Oussama Bentahar

Keywords : Brachytherapy, Lead protection, Positioning splints, Prosthetic rehabilitation, Radio, Removable

Citation Information : Hawari WE, Oumaima E, Merzouk N, Bentahar O. Lead Protection and Positioning Splints before Brachytherapy in Maxillofacial Prosthodontics: A Case Report. Int J Prosthodont Restor Dent 2021; 11 (2):799-804.

DOI: 10.5005/jp-journals-10019-1314

License: CC BY-NC 4.0

Published Online: 30-09-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

The prevalence of head and neck cancers increases worldwide, the therapeutic arsenal of its management mainly includes surgery, radiotherapy (RTH), and the combination of these two therapies. Chemotherapy is also used as an adjuvant treatment. Brachytherapy (BT) is indicated for localized head and neck cancers of the tumors of the lips and the nasal pyramid, the oral cavity, and the oropharynx. Lead protection and positioning splints are generally used when BT is provided. They help protect uninvolved tissues as the dose that will be delivered is important. They are made before BT and positioned during irradiation. This case report presents a clinical case of a patient with lip cancer for treatment with BT and for which a lead protection splint for maxillary arch protection and mandibular positioning splint was given.


PDF Share
  1. El Hawari W, Rokhssi H, Azhari M, et al. Radiotherapy and management in maxillofacial prosthodontic: part 1 - before radiotherapy. Integr J Med Sci 2021. 8. DOI: 10.15342/ijms.2021.386.
  2. Skowronek J. Current status of brachytherapy in cancer treatment – short overview. JCB 2017;9(6):581–589. DOI: 10.5114/jcb.2017.72607.
  3. Takácsi-Nagy Z, Martínez-Mongue R, Mazeron J-J, et al. American Brachytherapy Society task group report: combined external beam irradiation and interstitial brachytherapy for base of tongue tumors and other head and neck sites in the era of new technologies. Brachytherapy 2017;16(1):44–58. DOI: 10.1016/j.brachy.2016.07.005.
  4. Peiffert D, Coche-Dequéant B, Lapeyre M, et al. Curiethérapie des cancers de la tête et du cou: synthèse des recommandations européennes et principales indications. Cancer/Radiothérapie 2018;22(4):359–366. DOI: 10.1016/j.canrad.2017.12.005.
  5. Aggarwal H, Kumar P. Radiation stents: minimizing radiation-induced complications. South Asian J Cancer 2014;3(3):185. DOI: 10.4103/2278-330X.136812.
  6. Nam KY. The validity of oral prosthetic stents for maxillofacial cancer during radiation therapy: case report. Dent Oral Maxillofac Res 2020;6(2):1. DOI: 10.15761/DOMR.1000336.
  7. Yangchen K, Singh S, Aggarwal H, et al. Cerrobend shielding stents for buccal carcinoma patients. J Can Res Ther 2016;12(2):1102. DOI: 10.4103/0973-1482.144688.
  8. Wilke CT, Zaid M, Chung C, et al. Design and fabrication of a 3D–printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Print Med 2017;3(1):12. DOI: 10.1186/s41205-017-0021-4.
  9. Zaid M, Bajaj N, Burrows H, et al. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol 2019;14(1):148. DOI: 10.1186/s13014-019-1357-2.
  10. El Hawari W, Rokhssi H, Azhari M, et al. Radiotherapy and management in maxillofacial prosthodontic: part 3 - proposal for a joint sheet between the specialist in maxillofacial prosthodontics and the radiotherapist/oncologist. Integr J Med Sci 2021;8:2. DOI: 10.15342/ijms.2021.388.
  11. Bruno JS, Miranda-Silva W, da V, et al. Digital workflow for producing oral positioning radiotherapy stents for head and neck cancer. J Prosthod 2020;29(5):448–452. DOI: 10.1111/jopr.13155.
  12. Jain AR, Janani T. Clinical demonstration of various radiation stents- an overview. J Pharm Sci 2016;8:10.
  13. Yangchen K, Siddharth R, Singh S, et al. A pilot study to evaluate the efficacy of cerrobend shielding stents in preventing adverse radiotherapeutic effects in buccal carcinoma patients. J Can Res Ther 2016;12(1):314. DOI: 10.4103/0973-1482.154015.
  14. Grant SR, Williamson TD, Stieb S, et al. A dosimetric comparison of oral cavity sparing in the unilateral treatment of early stage tonsil cancer: IMRT, IMPT, and tongue-deviating oral stents. Adv Radiat Oncol 2020;5(6):1359–1363. DOI: 10.1016/j.adro.2020.08.007.
  15. Farajollahi AR, Bouzarjomehri F, Kiani M. Comparison between clinically used irregular fields shielded by cerrobend and standard lead blocks. J Biomed Phys Engineer 2015;5(2):77.
  16. Doi H, Tanooka M, Ishida T, et al. Utility of intraoral stents in external beam radiotherapy for head and neck cancer. Rep Pract Oncol Radiother 2017;22(4):310–318. DOI: 10.1016/j.rpor.2017.03.002.
  17. Chen D, Chen X, Chen X, et al. The efficacy of positioning stents in preventing oral complications after head and neck radiotherapy: a systematic literature review. Radiat Oncol 2020;15(1):90. DOI: 10.1186/s13014-020-01536-0.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.